Found: 2
Select item for more details and to access through your institution.
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 1, doi. 10.1007/s10637-017-0500-x
- By:
- Publication type:
- Article
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146115
- By:
- Publication type:
- Article